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NFjBAdipocytes are continuously stimulated by proinﬂammatory cytokines such as TNFa, which cause
adipocyte dysfunction by facilitating the inﬂammatory response. Although miR-130 was reported
to be an important regulator of adipogenesis by targeting PPARc mRNA, little is known about the
mechanisms regulating miR-130 expression during the proinﬂammatory response. Here, we
examined miR-130 levels in white adipose tissue (WAT) from high-fat diet (HFD) mice and
TNFa-stimulated adipocytes. Primary transcripts of miR-130 were increased after TNFa stimulation,
indicating that induction of miR-130 during the pro-inﬂammatory response is regulated by a tran-
scriptional event. A chromatin immunoprecipitation assay showed that p65 binding to the promoter
regions of miR-130 was enhanced after TNFa treatment. Taken together, our ﬁndings suggest that
induction of miR-130 by TNFa is responsible for adipocyte dysfunction.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Inﬂammation is a key characteristic of metabolic syndromes
such as obesity and type II diabetes. Adipocytes from obese sub-
jects produce several chemokines and cytokines such as tumor
necrosis factor alpha (TNFa), interleukin (IL)-1b, and IL-6. These
proinﬂammatory cytokines facilitate the differentiation of macro-
phages by recruiting monocytes into the adipose tissue; this pro-
cess is linked to adipocyte dysfunction [1]. Although critical
factors related to adipocyte dysfunction in the obese have not been
fully determined, the prevailing hypothesis is that cytokines gener-
ated by adipocytes are responsible for the recruitment of immune
cells to obese adipose tissue and for the promotion of monocyte
differentiation to M1 macrophages to initiate systemic inﬂamma-
tion [2]. Inﬂammatory responses in the adipose tissue could be in-
duced by extracellular and intracellular stimuli from overnutrition,
increased endoplasmic reticulum (ER) stresses, levels of free fatty
acids, and apoptosis of adipocytes. The canonical inﬂammatory sig-
naling pathway to activate nuclear factor j B (NFjB) is also respon-
sible for adipocyte dysfunction in obese subjects [3].
TNFa is a well-known pro-inﬂammatory cytokine that inﬂu-
ences the expression of diverse immune and inﬂammatory re-
sponse genes in various cell types through the activation ofseveral DNA binding proteins including NFjB and activator protein
1 (AP-1) [4,5]. TNFa regulates multiple cellular processes such as
proliferation, apoptosis, inﬂammation, and energy metabolism
[6,7]. TNFa disrupts insulin signaling and sensitivity in adipose tis-
sues. Adipocytes generate TNFa, IL-6, and IL-1b; the levels of cyto-
kines were shown to be elevated in both adipose tissue and plasma
in mice fed a high-fat diet (HFD) [8]. Furthermore, TNFa depletion
prevented HFD-induced insulin resistance [8,9].
Several studies have established that TNFa affects adipogenesis
and insulin signaling. TNFa-mediated down-regulation of peroxi-
some proliferator activator receptor gamma (PPARc) is closely
linked to adipocyte dysfunction [10]. PPARc expression can be reg-
ulated at multiple levels including transcription, translation, mRNA
stability, and turn-over of PPARc by TNFa [11–18].
microRNAs (miRNAs) are a class of small non-coding RNAs that
regulate gene expression in eukaryotes [19]. miRNAs interact with
target mRNAs by forming incomplete base pairing and they nega-
tively regulate the expression of target mRNAs by inhibiting trans-
lation or by destabilizing mRNAs. Several reports have indicated
that miRNAs are involved in the regulation of adipogenesis and
fat cell metabolism [20–25]. In a previous study, miR-130a and
miR-130b (miR-130) were identiﬁed as novel regulators of adipo-
genesis by targeting PPARc, a master regulator of adipogenesis.
However, regulation of miR-130 by TNFa and its role in adipose tis-
sues have not yet been elucidated.
Here, we report the molecular evidence for PPARc regulation by
miR-130 during TNFa-induced adipocyte dysfunction. We show
3854 C. Kim et al. / FEBS Letters 587 (2013) 3853–3858that the expression levels of miR-130 were regulated by TNFa in
adipocytes, and up-regulation of miR-130 resulted in adipocyte
dysfunction through down-regulation of PPARc.
2. Materials and methods
2.1. Cell culture, differentiation, transfection, and treatment
NIH-3T3-L1 cells were cultured in Dulbecco’s modiﬁed essential
medium (DMEM, Invitrogen), supplementedwith 10% newborn calf
serum and antibiotics (Gibco). To induce adipocyte differentiation,
3T3-L1 cellswere incubatedwith 0.5 mM IBMX (Sigma), 1 lMdexa-
methasone (Sigma), and 167 nM insulin (Sigma) for 2 days, then
incubated with 167 nM insulin for 2 days, and further incubated
with DMEM/10% FBS with insulin for 2 more days. Differentiated
3T3-L1 cells were maintained in DMEM/10% FBS up to 8 days [26].
miRNAs (Ambion) and control siRNAs (Genolution) were transfec-
tedwith lipofectamine (Invitrogen) orNucleofector (Amaxa). Differ-
entiated adipocytes were incubated with 10 lg/ml of TNFa or PBS
overnight. White adipose tissues (WATs) from C57BL/6 mice fed a
chow-diet (CD) or an HFD for 8 weeks were isolated.
2.2. RNA analysis
Total RNAswere prepared fromwhole cells orWATs byusing Tri-
zol (Invitrogen). After reverse transcription (RT) using randomhexa-
mers and reverse transcriptase (Toyobo), the abundance of
transcripts was assessed by quantitative (q)PCR analysis using the
SYBR green PCR master mix (Kapa Biosystems) and gene-speciﬁc
primer sets. The primer sequences are listed in Table 1. RT-qPCR
analysis was performed on the Applied Biosystems 7300 Real-Time
PCR system (Applied Biosystems). Individual microRNAs were fur-
ther quantiﬁed using the Taqman microRNA detection assay (Ap-
plied Biosystems) or QuantiMir™ cDNA Kit (System Biosciences
Inc.). For the Taqman microRNA detection assay, miRNA-speciﬁc
primer sets supplied by the manufacturer were used in RT-qPCR.
For QuantiMir™ cDNA analysis, forward primers were designed to
be the exact sequences of the miRNAs in the miRBase database,
and a universal reverse primer was used from the kit [20].
2.3. Chromatin immunoprecipitation (ChIP)
ChIP was done as previously described [27]. After crosslinking
with 1% formaldehyde, cells were lysed in SDS lysis buffer contain-
ing 50 mM Tris–HCl (pH 8.0), 1% SDS, 10 mM EDTA, and protease
inhibitor cocktail. Chromatin was fragmented by sonication (Bio-
ruptor) with 6 cycles (30 s on and 30 s off) and diluted in dilution
buffer containing 16.7 mM Tris–HCl (pH 8.0), 167 mM NaCl,
1.2 mM EDTA, and 1.1% Triton-X. After pre-clearing, diluted super-
natants were incubated with 1 lg of anti-polII (Millipore), anti-p65
(Santa Cruz Biotech), and control IgGs (mouse and rabbit, Santa
Cruz Biotech) antibodies for overnight at 4 C and further precipi-
tated with protein A-Sepharose beads. Immune complexes were
washed with washing buffer containing 20 mM Tris–HCl (pH
8.0), 150 mM NaCl, 2 mM EDTA, 1% Triton-X, and 0.1% SDS, and
then incubated with protease K (Fermentas) at 55 C. After centri-
fugation, the DNAs were precipitated with ice-cold EtOH at 20 C.
The quantitative analysis of puriﬁed DNA was assessed by PCR
using speciﬁc primers for p65 binding promoter regions of miR-
130a and miR-130b.
2.4. Western blot analysis
Whole-cell lysates and immunoprecipitants were prepared,
separated by electrophoresis in SDS-containing polyacrylamidegels, and transferred onto polyvinylidene diﬂuoride (PVDF) mem-
branes (Millipore). Incubation with primary antibodies to detect
p65 (Santa Cruz Biotech) was followed by incubation with the
appropriate secondary antibody conjugated with horseradish per-
oxidase (HRP) (Santa Cruz Biotech); proteins were detected using
the Clarity™ Western ECL Substrate (Bio-Rad).
3. Results
3.1. Proinﬂammatory signaling increased miR-130 expression
HFD-induced obesity recruits macrophages around the adipose
tissue and promotes an inﬂammatory response that resulted in
adipocyte dysfunction [10]. A previous study has shown that
miR-130a and-130b could regulate adipogenesis by targeting
PPARc, a pivotal regulator of adipocyte differentiation and function
[20]. To determine miR-130 levels during HFD-induced obesity, we
analyzed the expression levels of miR-130 from WAT of CD or HFD
mice. The levels of miR-130a and -130b were up-regulated to 3.9-
and 2.9-fold, respectively, in WAT from HFD mice compared to CD
mice (Fig. 1A). To examine whether up-regulation of miR-130a and
miR-130b in the WATs from HFD mice is regulated transcription-
ally, we examined the levels of their primary transcripts. As shown
Table 2, miR-130a and miR-130b are encoded in chromosome 2
and chromosome 16 of the mouse genome, respectively. RT-qPCR
results showed that their primary transcripts, pri-miR-130a and
pri-miR-130b, in the HFD group were also 2.8- and 4.1-fold higher,
respectively, than the levels in the CD group (Fig. 1B). Based on
these data, we hypothesized transcriptional regulation of both
miR-130a and miR-130b during HFD-induced obesity.
To examine the expression levels ofmiR-130 in a cell culture sys-
tem, we used adipocytes differentiated from mouse preadipocyte
NIH-3T3-L1 cells upon hormonal stimuli, as described in the Mate-
rials and Methods. TNFa is a well-characterized proinﬂammatory
cytokine and is responsible for macrophage activation in adipose
tissues [5]. We examined the levels of miR-130 in TNFa-stimulated
adipocytes. Fully differentiated adipocytes were exposed to a low
concentration of TNFa for 16 h to induce chronic inﬂammatory
signaling cascades, which is similar to the environment of HFD-
induced obesity. After RNA isolation, the expression levels of miR-
130 and their primary transcripts were determined by RT-qPCR.
TNFa treatment resulted in a 6.8- and 12.9-fold increase of both
miR-130a andmiR-130b, respectively, (Fig. 2A); their primary tran-
scripts were also increased to 4.5- and 6.5-fold, respectively, in the
TNFa-treated group (Fig. 2B). Taken together, these results suggest
that both miR-130a and miR-130b are induced by the TNFa-medi-
ated proinﬂammatory response in adipocytes.
3.2. TNFa mediated down-regulation of PPARc and its target genes
PPARc down-regulation by TNFa is closely linked to adipocyte
dysfunction [10]. PPARc expression could be regulated at both
the transcriptional level and the post-translational level by TNFa
[12,14].
To show TNFa-mediated adipocyte dysfunction, we measured
the levels of PPARc and its target genes, including adipsin, aP2,
and LPL in WAT from HFD mice as well as in adipocytes stimulated
with TNFa. As shown in Fig. 3A, PPARc expression was signiﬁcantly
decreased in WAT of HFD mice compared to that of CD mice, thus
resulting in the down-regulation of its target genes. A similar effect
was observed in adipocytes exposed to TNFa (Fig. 3B). Chronic
exposure of adipocytes to TNFa resulted in the decrease of
PPARc, adipsin, aP2, and LPL. These results indicate that the
TNFa-mediated proinﬂammatory response is responsible for
adipocyte dysfunction by down-regulating PPARc expression.
Table 1
Primer sequences in this study.
Forward primer Reverse primer
Primers for ChIP
mmu-miR-130a promoter A 50-TGAGTTGTGCAGCAAGTATGGC-30 50-AGAGCAGGAGGGTCCTGAAA-30
mmu-miR-130a promoter B 50-AGTTGCCAGTTTCCTGCCCAA-30 50-GGGTGCTGGACTTGGAGAT-30
mmu-miR-130a promoter C 50-TGAAAGGCAGTTCCTCTGCT-30 50-TGATCCTTCCATAGGCCTCAGT-3
mmu-miR-130b promoter A 50-TCCAGGTCCATCCATTTGCCTA-30 50-CCCTCAACAGAGGAATGGATAC -30
Negative control region 50-ACCTCACCAGAATCAGAAGCCTGT-30 50-AGTGCAACCTAGTCAGAGCA-30
Primers for RT-qPCR
pri-mmu-miR-130a 50-GTGACGTGAGCTGAGTGTGG-30 50-AGGTGGGAGAAAATGCAGTG-30
pri-mmu-miR-130b 50-ACTGACAGGCTTGTTGGACACT-30 50-TGGTTCTCAGCATCCACCTT-30
mPPARc 50-TCGCTGATGCACTGCCTATG-30 50-GAGAGGTCCACAGAGCTGATT-30
mGAPDH 50-AGGTCGGTGTGAACGGATTTG-30 50-TGTAGACCATGTAGTTGAGGTCA-30
mPPARc 50-TCGCTGATGCACTGCCTATG-30 50-GAGAGGTCCACAGAGCTGATT-30
mAdipsin 50-CATGCTCGGCCCTACATGG-30 50-CACAGAGTCGTCATCCGTCAC-30
maP2 50-GGGGCCAGGCTTCTATTCC-30 50-GGAGCTGGGTTAGGTATGGG-30
mLPL 50-GGGAGTTTGGCTCCAGAGTTT-30 50-TGTGTCTTCAGGGGTCCTTAG-30
Mouse miR-130a 50-CAGUGCAAUGUUAAAAGGGCAU-3 Universal primers
Mouse miR-130b 50-CAGUGCAAUGAUGAAAGGGCAU-3 Universal primers
Mouse U6 snRNA 50-CGCAAGGATGACACGCAAATTC-30 Universal primers
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Fig. 1. HFD-induced inﬂammation increased miR-130 in WAT. Total RNAs were isolated from white adipose tissues (WAT) of chow diet (CD) or high-fat diet (HFD) mice. The
expression levels of either mature microRNAs (miR-130a and miR-130b) (A) or their primary transcripts (pri-miR-130a and pri-miR-130b) (B) were analyzed by reverse
transcription (RT) and quantitative (q) PCR using speciﬁc primer sets as described in materials and methods. Data represent mean ± S.E.M. of experiments from six different
mice. (n = 6), ⁄⁄P < 0.01.
Table 2
Genetic localization of mmu-miR-130a and-130b.
miRNAs (NCBI reference
sequence)
Chromosome
number
pre-miRNA cording region
(base)
mmu-miR-130a
(NC_000068.7)
Chromosome 2 84741115 to 84741178
(65 bp)
mmu-miR-130b
(NC_000082.6)
Chromosome 16 17124061 to 17124142
(82 bp)
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PPARc expression
A previous study has shown miR-130 as a potential negative
regulator of adipogenesis by targeting PPARc [20]. miR-130 and
PPARc expression showed an inverse correlation during adipo-
cyte differentiation. Inhibition of miR-130 promoted adipogene-
sis, while up-regulation of miR-130 down-regulated it [20]. We
have shown an up-regulation of miR-130 after a pro-inﬂamma-
tory response in both adipose tissues and adipocytes. From these
observations, we hypothesized that TNFa-induced miR-130 is
responsible for the down-regulation of PPARc and adipocyte dys-
function. To test this hypothesis, we examined PPARc expression
after TNFa stimulation in anti-miR-130-transfected adipocytes.
Consistent with our hypothesis, TNFa stimulation decreased
the level of PPARc up to 30% in control siRNA-transfected adipo-
cytes, which indicated that pro-inﬂammatory responses medi-
ated by TNFa treatment resulted in adipocyte dysfunction by
down-regulating PPARc expression. However, inhibition of miR-
130a and miR-130b using speciﬁc miRNA inhibitors signiﬁcantly
restored PPARc expression upon TNFa stimulation. These results
indicate that miR-130 induced by the TNFa-mediated inﬂamma-
tory response was responsible for the regulation of PPARc
expression.3.4. The NFjB pathway, activated by TNFa, mediated the induction of
miR-130
TNFa mediates the activation of NFjB and JNK signaling [14].
Chronic exposure of TNFa to 3T3-L1 cells leads to adipocyte dys-
function through activation of signaling mediated by NFjB and
AP-1 [28,29]. To predict potential NFjB binding sites, we used
the TESS (http://www.cbil.upenn.edu/tess?RQ=WELCOME) site
and identiﬁed 3 putative p65 binding sites for miR-130a and 1
putative binding site for miR-130b. Their localization and pre-
dicted binding sites are represented in Fig. 5A. Based on their prob-
ability of binding afﬁnity to promoter regions, we tested the
association of p65 to each promoter region through chromatin
immunoprecipitation (ChIP). Endogenous p65 was precipitated
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Fig. 2. TNFa promoted the expression of miR-130 in adipocytes. Fully differentiated adipocytes were incubated with TNFa for 16 h. After total RNA isolation, the expression
levels of either mature microRNAs (miR-130a and miR-130b) (A) or their primary transcripts (pri-miR-130a and pri-miR-130b) (B) were analyzed by RT-qPCR using speciﬁc
primer sets. Data represent mean ± S.E.M. from three independent experiments. ⁄⁄P < 0.01.
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Fig. 3. TNFa mediated the downregulation of PPARc and its target genes. (A) After total RNA isolation from WATs of CD or HFD mice (n = 6), the expression levels of PPARc
and its target genes, adipsin, aP2 and LPL were assessed by RT-qPCR using speciﬁc primer sets. (B) 3T3-L1 preadipocytes were differentiated for 8 days under hormonal
regulation and further incubated with TNFa for 16 h. After isolation of total RNAs, the gene expression was analyzed as described in (A). Data represent mean ± S.E.M. from
three independent experiments. ⁄⁄P < 0.01, ⁄P < 0.05.
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Fig. 4. Inhibition of miR-130 rescued TNFa-induced downregulation of PPARc. AntagomiRs for miR-130a and miR-130b were ectopically transfected into 3T3-L1 adipocytes
for 48 h and cells were stimulated with TNFa for 16 h. Total RNAs were isolated and PPARc mRNA (A) or Adipsin mRNA (B) level was analyzed by RT-qPCR using speciﬁc
primer set. Data represent mean ± S.E.M. from three independent experiments. ⁄P < 0.05.
3856 C. Kim et al. / FEBS Letters 587 (2013) 3853–3858using a speciﬁc antibody (Fig. 5B), and RNA polymerase II (pol II)
was used as the positive control to detect the active transcription
of each transcript. After IP of the chromatin complex containing
p65 or pol II, enriched DNA fragments in each IP complex were
analyzed by PCR using the speciﬁc primer sets shown in Table 1.
As shown in Fig. 5C, p65 was associated with 3 different regions
for miR-130a and 1 region for miR-130b. These interactions were
decreased after treatment with sodium salicylate, an IjB kinase b
(IKKb) inhibitor (Fig. 5D and E). Taken together, these resultsindicate that the expression of miR-130 was regulated by NFjB
signaling after TNFa-mediated stimulation.
4. Discussion
Obesity is linked to chronic activation of inﬂammatory path-
ways in both adipocytes and macrophages. Although NFjB was
ﬁrst characterized in hematopoietic cells, subsequent studies have
revealed that NFjB activation can occur in most cell types. Local
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Fig. 5. NFjB pathway activated by TNFa is responsible for the induction of miR-130. (A) Schematics of localization of NFjB binding sites on the promoter regions of miR-130a
and miR-130b. Putative NFjB binding sites were predicted using TESS web-based tool and presented as light gray. (B) Endogenous p65 was precipitated by
immunoprecipitation and further analyzed by WB. (C) After incubation with TNFa for 16 h, cells were harvested for chromatin immunoprecipitation (ChIP). Chromatin
complexes were prepared by sonication and precipitated using p65 speciﬁc antibody. DNAs were recovered from IP samples and analyzed by PCR using speciﬁc primer set as
shown in Table 1. (D and E) Cells were incubated with TNFa in the presence or absence of 1 mM sodium salicylate then p65 binding to promoter region was assayed. DNA
fragments were isolated and further analyzed by PCR (D) or quantitative PCR (E). Data are representative from three different experiments. ⁄P < 0.05.
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macrophage relocalization and initiate the inﬂammatory cascade
[2]. Increased TNFa expression in the adipose tissues from obese
mice has provided a strong link between obesity and chronic
inﬂammation [8]. A lack of TNFa function improved insulin sensi-
tivity and glucose homeostasis, conﬁrming that inﬂammatory re-
sponses mediated by TNFa play in a critical role in the regulation
of insulin action in obesity [9,30], and overexpression of TNFa in
adipose tissues was also related to the acquisition of insulin resis-
tance [28,31–33].
PPARc is a critical transcription factor of fat cell development
and it is tightly regulated during adipogenesis [34–36]. Previous
studies have demonstrated that miRNAs, including miR-130 and
miR-27, regulated adipogenesis by targeting PPARc [20,37,38].
Although these miRNAs are negative regulators of PPARc, the reg-
ulation of miRNAs during pathophysiology has not been eluci-
dated. In this study, we report for the ﬁrst time that miR-130
was induced by TNFa treatment, and up-regulation of miR-130
caused adipocyte dysfunction in both mice WAT and differentiated
adipocytes. The NFjB signaling pathway activated by TNFa in-
creased p65 binding to upstream regions of both miR-130a and
miR-130b, and thus led to enhanced transcription of both pri-
miR-130a and pri-miR-130b, respectively. Although miR-27 also
responsible for the regulation of PPARc mRNA, we did not seesigniﬁcant changes of pri-miR-27 transcription after TNFa stimula-
tion (data not shown). The regulation of miR-27 expression by
TNFa during adipocyte dysfunction needs to be investigated fur-
ther. Taken together, we suggest a novel regulatory mechanism
of PPARc expression during the TNFa-mediated proinﬂammatory
response in adipocytes.
During searching the literatures, we found that the expression
level of miR-130b was various in experimental systems. Some
studies presented down-regulation of miR-130b in obese or HFD
mice [39,40], while some other studies showed up-regulation of
miR-130b in ob/ob or HFD mice [41,42]. These discrepancies
among studies might be resulted from differences such as origin
of fat cells (e.g. fat samples from subcutaneous or visceral fat
depots, species or strain of animals) and high fat diet conditions
(e.g. fat composition of diet, duration of HFD). In this report, we
found that the expression of miR-130a and miR-130b was up-
regulated in the WAT from HFD mice as well as TNFa-stimulated
adipocytes (Figs. 1 and 2 and our unpublished data), which
indicates that pro-inﬂammatory signaling is responsible for the
up-regulation of miR-130 expression. However, comprehensive
and integrated analysis are required to explain the differential
expression miRNAs in various obesity-related models.
We showed that PPARc expression in anti-miR-130-transfected
adipocytes was restored after TNFa stimulation (Fig. 4), thus
3858 C. Kim et al. / FEBS Letters 587 (2013) 3853–3858indicating that inhibition of miR-130 attenuated TNFa-mediated
PPARc down-regulation. These data support our hypothesis that
miR-130 induced by a proinﬂammatory response is involved in
adipocyte dysfunction by down-regulating PPARc expression. Even
though we showed inhibitory effects of anti-miR-130s after TNFa
stimulation compared to the control siRNA transfected group,
antagomiRs partially restored PPARc expression after TNFa stimu-
lation. These data imply that other regulatory mechanisms are also
responsible for PPARc down-regulation after TNFa stimulation,
including transcriptional or post-translational regulation of PPARc
[12,14], which may contribute to the partial restoration of PPARc
by miR-130. In addition to multiple pathways of PPARc regulation,
we showed experimental evidence for the post-transcriptional reg-
ulation of PPARc during the TNFa-mediated inﬂammatory re-
sponse in adipocytes for the ﬁrst time. Our results provide a
novel post-transcriptional regulatory mechanism of PPARc expres-
sion by miR-130 in response to TNFa stimulation in adipocytes.
Further studies are required to investigate the pathophysiological
functions of miR-130 in vivo and they will involve the monitoring
of metabolic changes in fat tissues after stress responses that are
responsible for adipocyte dysfunction such as HFD-induced obes-
ity. The results from these studies provide additional insight into
PPARc regulation by miR-130 during proinﬂammatory responses
leading to adipocyte dysfunction.
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